INDV · Indivior Pharmaceuticals, Inc. · Documents

$35.25 +0.48 (+1.38%)

Market Cap

$4.10B

118.01M

Volume · Oct 20 1.93M Avg daily vol (3M) 2.3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-01-19	—
6-K	—	2024-01-18	—
6-K	—	2024-01-17	—
6-K	—	2024-01-16	—
6-K	—	2024-01-16	—
6-K	—	2024-01-12	—
6-K	—	2024-01-11	—
6-K	—	2024-01-10	—
6-K	—	2024-01-09	—
6-K	—	2024-01-08	—
6-K	—	2024-01-05	—
6-K	—	2024-01-05	—
6-K	—	2024-01-04	—
6-K	—	2024-01-03	—
6-K	—	2024-01-02	—
6-K	—	2024-01-02	—
6-K	—	2023-12-29	—
6-K	—	2023-12-28	—
6-K	—	2023-12-27	—
6-K	—	2023-12-22	—
6-K	—	2023-12-22	—
6-K	—	2023-12-22	—
6-K	—	2023-12-21	—
6-K	—	2023-12-21	—
6-K	—	2023-12-20	—
6-K	—	2023-12-20	—
6-K	—	2023-12-19	—
6-K	—	2023-12-18	—
6-K	—	2023-12-15	—
6-K	—	2023-12-14	—
6-K	—	2023-12-13	—
6-K	—	2023-12-12	—
6-K	—	2023-12-12	—
6-K	—	2023-12-11	—
6-K	—	2023-12-08	—
6-K	—	2023-12-07	—
6-K	—	2023-12-06	—
6-K	—	2023-12-05	—
6-K	—	2023-12-05	—
6-K	—	2023-12-04	—
6-K	—	2023-12-01	—
6-K	—	2023-12-01	—
6-K	—	2023-11-30	—
6-K	—	2023-11-29	—
6-K	—	2023-11-28	—
6-K	—	2023-11-27	—
6-K	—	2023-11-27	—
6-K	—	2023-11-24	—
6-K	—	2023-11-22	—
6-K	—	2023-11-22	—

Showing 301–350 of 386 filings

Key facts CIK 1625297 CUSIP 45579U109 13F (30d) 32 filings 32 filers Visit website Investor relations